Emerging Effects of IL-33 on COVID-19

Emerging Effects of IL-33 on COVID-19

Since the start of COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), more than 6 million people have lost their lives worldwide directly or indirectly. Despite intensified efforts to clarify the immunopathology of COVID-19, the key factors and processes that t...

Full description

Bibliographic Details
Main Authors:	Yuan Gao, Luwei Cai, Lili Li, Yidan Zhang, Jing Li, Chengliang Luo, Ying Wang, Luyang Tao
Format:	Article
Language:	English
Published:	MDPI AG 2022-11-01
Series:	International Journal of Molecular Sciences
Subjects:	COVID-19 IL-33 neutrophils innate lymphocytes dendritic cells macrophages
Online Access:	https://www.mdpi.com/1422-0067/23/21/13656

Similar Items

IL-33 Enhances IFNγ and TNFα Production by Human MAIT Cells: A New Pro-Th1 Effect of IL-33
by: Mourad Azzout, et al.
Published: (2021-09-01)

Innate-Type and Acquired-Type Allergy Regulated by IL-33
by: Tomohiro Yoshimoto, et al.
Published: (2014-01-01)

The IL-33/ST2 Axis in Immune Responses Against Parasitic Disease: Potential Therapeutic Applications
by: Nathan Ryan, et al.
Published: (2020-04-01)

IL-33 at the Crossroads of Metabolic Disorders and Immunity
by: Lei Tu, et al.
Published: (2019-01-01)

The Expressions of TSLP, IL-33, and IL-17A in Monocyte Derived Dendritic Cells from Asthma and COPD Patients are Related to Epithelial–Macrophage Interactions
by: Magdalena Paplinska-Goryca, et al.
Published: (2020-08-01)

Association of IL-33, IL1RL1 gene polymorphisms with serum IL-33 levels and risk of asthma in adults and asthmatic bronchitis in children (Chinese)
by: Guangyang Zhang, et al.
Published: (2018-09-01)

IL-33 promotes innate lymphoid cell-dependent IFN-γ production required for innate immunity to Toxoplasma gondii
by: Joseph T Clark, et al.
Published: (2021-04-01)

Deficiency in IL-33/ST2 Axis Reshapes Mitochondrial Metabolism in Lipopolysaccharide-Stimulated Macrophages
by: Huadan Xu, et al.
Published: (2019-02-01)

IL-33 deficiency causes persistent inflammation and severe neurodegeneration in retinal detachment
by: Josy Augustine, et al.
Published: (2019-12-01)

The enhanced effect and underlying mechanisms of mesenchymal stem cells with IL-33 overexpression on myocardial infarction
by: Yueqiu Chen, et al.
Published: (2019-09-01)

Inflammatory Cells in Atherosclerosis
by: Marcelle Mehu, et al.
Published: (2022-01-01)

House Dust Mite Induces Bone Marrow IL-33-Responsive ILC2s and T<sub>H</sub> Cells
by: Emma Boberg, et al.
Published: (2020-05-01)

Emerging roles for IL-25 and IL-33 in colorectal cancer tumorigenesis
by: Eric Jou, et al.
Published: (2022-10-01)

IL-33 in Mental Disorders
by: Gianluca Pandolfo, et al.
Published: (2021-03-01)

Involvement of IL-33 in the Pathophysiology of Systemic Lupus Erythematosus: Review
by: Julie Sarrand, et al.
Published: (2022-03-01)

IL-33 Alarmin and Its Active Proinflammatory Fragments Are Released in Small Intestine in Celiac Disease
by: Federico Perez, et al.
Published: (2020-10-01)

The Relationship between the Genetic Polymorphisms of Interleukin-33 (IL-33) and Interleukin-1 Receptor-Like 1 (IL1R1) with the Levels of Interleukin-33 in Patients with Asthma and Multiple Sclerosis
by: Maryam Ahmadi, et al.
Published: (2016-02-01)

IL-33 and IL-18 in Inflammatory Bowel Disease Etiology and Microbial Interactions
by: Michelle A. Williams, et al.
Published: (2019-05-01)

Senescent fibroblast facilitates re-epithelization and collagen deposition in radiation-induced skin injury through IL-33-mediated macrophage polarization
by: Yan Chen, et al.
Published: (2024-02-01)

IL-33 ameliorates experimental colitis involving regulation of autophagy of macrophages in mice
by: Zhongyan Wang, et al.
Published: (2019-01-01)

The Pleiotropic Immunomodulatory Functions of IL-33 and Its Implications in Tumor Immunity
by: Claudia Afferni, et al.
Published: (2018-11-01)

Sera Level and Polymorphism of Interleukin-33 Gene in Iraqi Females Patients with Breast Cancer
by: Asmaa M. Salih Almohaidi, et al.
Published: (2021-01-01)

IL33: Roles in Allergic Inflammation and Therapeutic Perspectives
by: Ben C. L. Chan, et al.
Published: (2019-03-01)

Macrophages reprogramming improves immunotherapy of IL-33 in peritoneal metastasis of gastric cancer
by: Keying Che, et al.
Published: (2024-01-01)

The Controversial Role of IL-33 in Lung Cancer
by: Keshan Yang, et al.
Published: (2022-05-01)

M2 Macrophages promote IL-33 expression, ILC2 expansion and mucous metaplasia in response to early life rhinovirus infections
by: Mingyuan Han, et al.
Published: (2022-08-01)

IL11 Stimulates IL33 Expression and Proinflammatory Fibroblast Activation across Tissues
by: Anissa A. Widjaja, et al.
Published: (2022-08-01)

IL33 and Mast Cells—The Key Regulators of Immune Responses in Gastrointestinal Cancers?
by: Moritz F. Eissmann, et al.
Published: (2020-07-01)

IL-33 and IL-37: A Possible Axis in Skin and Allergic Diseases
by: Francesco Borgia, et al.
Published: (2022-12-01)

Sex Differences in IL-33-Induced STAT6-Dependent Type 2 Airway Inflammation
by: Hedi Zhao, et al.
Published: (2019-05-01)

The association between airway eosinophilic inflammation and IL-33 in stable non-atopic COPD
by: Damian Tworek, et al.
Published: (2018-06-01)

Recombinant Expression of Human IL-33 Protein and Its Effect on Skin Wound Healing in Diabetic Mice
by: Yunxian Li, et al.
Published: (2022-11-01)

IL-33 Ameliorates the Development of MSU-Induced Inflammation Through Expanding MDSCs-Like Cells
by: Ke Shang, et al.
Published: (2019-02-01)

Regulatory Mechanism of the IL-33–IL-37 Axis via Aryl Hydrocarbon Receptor in Atopic Dermatitis and Psoriasis
by: Gaku Tsuji, et al.
Published: (2023-09-01)

Serum IL-5, POSTN and IL-33 levels in chronic rhinosinusitis with nasal polyposis correlate with clinical severity
by: Hanna Zielińska-Bliźniewska, et al.
Published: (2022-06-01)

IL-33 receptor (ST2) deficiency downregulates myeloid precursors, inflammatory NK and dendritic cells in early phase of sepsis
by: Zivan M. Babic, et al.
Published: (2018-07-01)

Regulatory Mechanisms of IL-33-ST2-Mediated Allergic Inflammation
by: Hiroaki Takatori, et al.
Published: (2018-09-01)

Blockade of IL-33R/ST2 Signaling Attenuates Toxoplasma gondii Ileitis Depending on IL-22 Expression
by: Bernhard Ryffel, et al.
Published: (2019-04-01)

Less airway inflammation and goblet cell metaplasia in an IL-33-induced asthma model of leptin-deficient obese mice
by: Atsushi Kurokawa, et al.
Published: (2021-06-01)

Contribution of IL-33 to the Pathogenesis of Colorectal Cancer
by: Guanglin Cui, et al.
Published: (2018-11-01)